Reuters / Kyodo
- While Goldman Sachs expects earnings growth to push stocks higher in 2019, it’s cautious about what it sees as a lack of margin upside.
- The firm recommends buying stocks offering high revenue growth to counteract this trend, since they’re the most likely to keep seeing strong earnings expansion.
- Goldman identifies the 12 stocks is says will offer the best sales growth throughout the rest of 2019.
Profit growth has been the foremost driver of stock gains throughout the 10-year bull market. But what’s an investor to do as corporate earnings slow?
It’s an important question, and one that needs an answer amid forecasts that margins — which currently sit at a record high — have nowhere to go but down.
The answer is simple to Goldman Sachs: If traders can’t be guaranteed robust margin expansion, their only hope is to seek share appreciation through companies offering explosive top-line growth.
"Mounting pressures from wage inflation and other input costs will pressure margins, making further expansion from currently all-time high margins unlikely," David Kostin, Goldman’s chief US equity strategist, wrote in a client note. "As a result, growth in EPS will be driven entirely by top-line sales."
But recognizing that is the easy part. It’s decidedly more difficult to actually identify these companies. Luckily for hungry investors out there, Goldman has constructed a basket of stocks offering outsized revenue growth.
The firm finds that the group has beaten the benchmark S&P 500 by 400 basis points so far this year. Since margins were near all-time highs for the entire period, the basket’s success is compelling proof that investors should be seeking high-sales-growth companies.
Without further ado, here are the 12 stocks Goldman says will offer the highest revenue expansion this year.
12. Vertex Pharmaceuticals
Markets Insider
Ticker: VRTX
Industry: Healthcare
Market cap: $46 billion
Year-to-date return: 8%
2019 expected sales growth: 17%
Source: Goldman Sachs
11. Assurant
Markets Insider
Ticker: AIZ
Industry: Financials
Market cap: $6 billion
Year-to-date return: 13%
2019 expected sales growth: 17%
Source: Goldman Sachs
10. Centene
Markets Insider
Ticker: CNC
Industry: Healthcare
Market cap: $23 billion
Year-to-date return: -2%
2019 expected sales growth: 18%
Source: Goldman Sachs
See the rest of the story at Business Insider
See Also:
- Bank of America has a simple solution for companies looking to boost their stocks: Put more women in charge. Here are the charts that prove it.
- Goldman Sachs uncovered a trading strategy that’s crushed the market for 16 years — one the firm says will keep soaring in 2019
- We spoke to 2 veteran economists about how they survived the last 30 years of financial crises — and they explained why Wall Street millennials are ill-prepared to handle the next one
Source: Business Insider – jciolli@businessinsider.com (Joe Ciolli)